BNF:

Not listed

Status:

Do Not Prescribe (DNP)

Decision Date:

March 2015

Comments

DO NOT PRESCRIBE (DNP): NICE TA 332 not recommended for treating asymptomatic or minimally symptomatic metastatic hormone relapsed prostate cancer.

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again